title: RBC Warns Gilead (GILD) Faces Risk from Trump’s Price Cut Target
source: Yahoo
date: 2025-10-16
url: https://finnhub.io/api/news?id=d6309782940414e45994057909ffb7045df75c136861f03637b4ab2060e69563
Gilead Sciences, Inc. (NASDAQ:GILD) is one of the best stocks to buy according to Jim Simons’ Renaissance Technologies. On October 1, RBC analysts stated that Gilead Sciences, Inc. (NASDAQ:GILD) may face a negative impact if its key HIV medication, Biktarvy, is targeted by the proposed price cuts mentioned by President Trump. During an announcement related […]
